Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009579
Filing Date
2018-04-27
Accepted
2018-04-27 16:13:34
Documents
6
Period of Report
2018-04-27
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A xene-def14a_20180427.htm DEF 14A 3040463
2 GRAPHIC g2018042208562873017578.jpg GRAPHIC 2099
3 GRAPHIC g2018042208562886017579.jpg GRAPHIC 2099
4 GRAPHIC g2018042208561136917576.jpg GRAPHIC 3078
5 GRAPHIC g2018042208561862017577.jpg GRAPHIC 44623
6 GRAPHIC g2018042208561104417575.jpg GRAPHIC 3078
  Complete submission text file 0001564590-18-009579.txt   3118015
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36687 | Film No.: 18784015
SIC: 2834 Pharmaceutical Preparations